Navigation Links
Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act
Date:11/12/2010

expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in Transgenomic's filings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. Accordingly, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date of the release and Transgenomic does not undertake any duty to update this information, including any forward-looking statements, unless required by law.


'/>"/>
SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 2010
2. Transgenomic Develops New Assays to Detect EGFR Mutations Using COLD-PCR
3. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
4. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
5. Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
6. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
7. Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit
8. Transgenomic, Inc. Reports Third Quarter 2009 Results
9. Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease
10. Transgenomic, Inc. Reports Second Quarter 2009 Results
11. Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... CannLabs, Inc. (OTCQB: CANL), the leading ... methodologies relating to cannabis, today announced that it has ... from an existing stockholder of the Company. , ... from one of our existing stockholders,” stated Mark ... help accelerate our planned expansions into the Connecticut and ...
(Date:11/22/2014)... 2014  The element of surprise has been a ... strike without warning. Until now, epidemiologists had nothing to ... outbreak, resulting in suboptimal responses to both the H1N1 ... Photo - http://photos.prnewswire.com/prnh/20141121/160242 ... because virus gene structural changes have been found that ...
(Date:11/21/2014)... (PRWEB) November 20, 2014 Offering a ... Sartorius Entris Balance promotion . The Sartorius Entris ... a durable, high accuracy, and easy-to-maintain balance entry level ... Germany. It was designed to help customer’s bridge the ... a balance that is very durable. Sartorius is the ...
(Date:11/21/2014)... BlueInGreen, LLC ( BlueInGreen® ) ... and PCI, Inc., leading suppliers of ozone process ... selected to provide a new state-of-the-art ozone system ... Noland Wastewater Treatment. The new ozone disinfection ... gas dissolution technology, Pinnacle Ozone’s industry leading Zenith™ ...
Breaking Biology Technology:CannLabs Secures $750,000 Line Of Credit 2Viruses' Advantage of Surprise is Lost 2Pipette.com Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014 2City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4
... Known medically as atopic dermatitis (AD), eczema is ... the affected area of skin may result in redness, ... of the skin.(2) Immuno-modulators called topical calcineurin (cal-SEE-nur-in) inhibitors ... moderate or severe eczema(3) who fail to respond adequately ...
... BETHESDA, Md., Aug. 3 Micromet, Inc. ... novel, proprietary antibodies for the treatment of cancer, inflammation ... Orphan Drug Designation from the European Medicines Agency (EMEA) ... (ALL). Blinatumomab is a novel therapeutic antibody that ...
... 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ... relating to long-term treatment with Stimuvax were presented at ... 13th World Conference on Lung Cancer in San Francisco ... Goss from the Ottawa Hospital Cancer Centre, Ottawa, Ontario, ...
Cached Biology Technology:Five Questions About Protopic (tacrolimus) Ointment 2Five Questions About Protopic (tacrolimus) Ointment 3Five Questions About Protopic (tacrolimus) Ointment 4Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 4Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer 2Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer 3Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer 4
(Date:11/21/2014)... 2014 Strict laws against distracted driving and ... North American and European automotive sector towards gesture recognition ... systems that are intuitive and able to retrieve information ... New analysis from Frost & Sullivan,s ... Europe and North ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
(Date:11/10/2014)... began appearing on U.S. store shelves in early 2010, ... since. The small packets can be tossed into a ... liquid or powder. The convenience, though, has come with ... researchers at Nationwide Children,s Hospital found that from 2012 ... 17,230 children younger than 6 years of age swallowing, ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Study finds laundry detergent pods, serious poisoning risk for children 2
... available in French . Researchers at ... of Canada, the University of Toronto and the SETI ... highly unique spring located on Axel Heiberg Island in ... explains that the Lost Hammer spring supports microbial life, ...
... 3, 2010 A cancer conference dedicated to increased ... bridge Western and Native American approaches to disease and ... Navajos are learning about cancer, adopting measures to help ... opening up to new therapies. The 3rd annual ...
... This release is available in French . , ... Social Sciences, two teams of researchers led by Professor Barbara ... Goldsmiths, University of London, U.K., have brought research in intelligent ... have developed a highly sophisticated concept of interactive clothing whereby ...
Cached Biology News:Could life survive on Mars? Yes, expert says 23rd annual Ft. Defiance Cancer Awareness Conference set for June 5 23rd annual Ft. Defiance Cancer Awareness Conference set for June 5 3Innovative research reawakens human memories through intelligent textiles 2
... 0.15M NaCl, 20mM MOPS, pH 7.5, ... 1mM EGTA, 10 Properites: For selective ... DEAE chromatography, divalent cation activation plus ... Quality Assurance: routinely evaluated by dephosphorylation ...
Mouse monoclonal [6G11] to Cytohesin 1 + 2 ( Abpromise for all tested applications)....
HNF-1 Purified Anti-Mouse, Anti-Rat, Anti-Rabbit, Anti-Human clone 2, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Recombinant Porcine IL-1 alpha/IL-1F1, CF...
Biology Products: